Alufluoride Ltd Q4 FY2026: Aluminium Fluoride’s Quarter of Two Faces

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1. At a Glance

The latest quarter arrived with opposing forces at work. Revenue dipped 4.46% YoY to ₹51.6 Cr while net profit jumped 211% to ₹4.67 Cr—a gap that flagged one simple fact: the company compressed costs harder than it lost sales.

Operating margins tell a messier story. Q4 OPM of 18.97% sat below Q3’s 25.44%, suggesting that cost compression leaned on one-time factors rather than structural strength. Three years into a 40% sales growth sprint, the business delivered a 116% profit surge over five years—but Q4 hinted at deceleration.

The tension: strong balance-sheet credentials and double-digit ROE collide with working capital that’s sprawling and quarterly profit that hiccupped just as the year closed.

2. Introduction

Alufluoride Ltd, founded in 1984, holds the title of India’s largest producer of low bulk density aluminium fluoride. The company operates from Visakhapatnam, Odisha, feeding a small but critical customer base in domestic aluminium smelting and a growing export channel.

For five years, the business has grown revenue at 40% CAGR and profits at 116% CAGR. It is smaller than peers—₹360 Cr market cap—but ROE at 22% and ROCE at 24% sit above the sector median.

In June 2026, plant operations face temporary reduction due to Hydrofluosilicic Acid shortage. Three months later (May), the board appointed Aditya Akkineni as CEO, signalling management transition. The Jordan subsidiary, earmarked for divestment, still awaits resolution. These moves set the tone for a company in mid-narrative.

3. Business Model: WTF Do They Even Do?

Aluminium Fluoride dominates the revenue line at 97% of sales.

The product is a flux—it reduces the melting point of alumina in the smelting process, cutting energy bills for foundries. Customer concentration, once at 89% (FY21), has dispersed to 52.5% by end-FY24, reducing single-customer risk. Domestic buyers include Hindalco, Nalco, Vedanta. International buyers reached via subsidiaries include Emirates Global Aluminium and Aditya Birla Novelis.

Calcium Fluoride and Silica round out the product line but register as noise in the P&L.

The supply chain is tethered to raw material: Hydrofluosilicic Acid from CIL, IFFCO Paradeep, and Paradeep Phosphates. Current committed supply runs to ~13,000 TPA; capacity sits at 18,000 TPA as of FY24. The shortage announced in June 2026 exposes this choke point. Capex at ₹59 Cr in FY26 funded CWIP of ₹22.5 Cr, suggesting Phase 3 expansion is underway.

Geography: 61% Odisha (nearness to suppliers), 23% Chhattisgarh (smelter proximity), 12% Madhya Pradesh, 4% others. A regional play masquerading as a national franchise.

4. Financials Overview

Figures are consolidated, in ₹ crore.

The year-on-year story is deceptive. Q4 FY25 cratered on a tax spike (41% rate vs. 25% normalized), leaving a weak base. Strip that out, and Q4 FY26 profit was actually softer—the 211% headline masks an underlying contraction.

Operating profit of ₹9.79 Cr fell below ₹14 Cr in the prior quarter, driving OPM to 18.97% from 23.93%. Q3 had benefited from better product mix or input cost timing; Q4 saw a reversion. Other income swung negative (−₹0.53 Cr), adding friction.

Full-year FY26 revenue reached ₹208.8 Cr (+10.7% vs. FY25’s ₹188.5 Cr). Net profit rose to ₹25.1 Cr (+38.9%). Over 10 quarters, the trend is up, but Q4 is a reminder that this is a cyclical margin story riding on commodity input costs.

5. Market Expectations & Historical Multiples

This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.

The market currently pays 14.3x annualized earnings, below its own five-year median of 20.3x and the peer median of 21x for commodity-chemical names in the set (SRF, GNFC, GHCL, Deepak Fertilis).

Return metrics remain firm: ROE at 22.1% sits above its own five-year average and above most peers barring SRF and Tanfac. ROCE at 24.2% is a standout, implying the capital deployed is earning strong incremental returns.

The market appears to be pricing in two things at once: confidence in capital efficiency and caution on cyclical margin compression—hence the sub-peers multiple despite superior returns. The data suggests the market is awaiting proof that capex cycles and supply-chain constraints do not erode returns.

6. What’s